A study team is preparing to initiate a Phase II trial for a novel colon cancer therapy. By signing the Form FDA 1572, the investigator is certifying that the investigator has:
Form FDA 1572 is the ''Statement of Investigator'' for IND studies.
21 CFR 312.53(c)(1)(vi)(b): Requires investigators to ''read and understand the Investigator's Brochure.''
By signing, the investigator also agrees to comply with regulations, maintain records, and supervise study conduct.
Other options (B--D) are not part of 1572 requirements.
Correct answer: A.
21 CFR 312.53(c)(1)(vi)(b).
Ilda
2 months agoMerri
2 months agoCaitlin
2 months agoGilma
3 months agoLuther
3 months agoHassie
3 months agoHassie
3 months agoKatlyn
4 months agoTegan
4 months agoShonda
4 months agoRima
4 months agoJulian
4 months agoAilene
4 months agoHuey
5 months ago